Atlas Trials

Autoimmunity Contributes to the Severe Progression of COVID-19

Clinical trial NCT04967781 · COMPLETED

Trial details

NCT number
NCT04967781
Sponsor
Zhongnan Hospital
Status
COMPLETED
Study type
OBSERVATIONAL
Coronavirus Disease 2019
Start date
2020-03-10
Primary completion
2021-05-27
Enrollment
162

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.